Purpose The aim of this observational study was to describe the type, number, and serum concentration levels of psychotropic drugs in elderly patients, on admission to a geriatric psychiatric inpatient unit. We further wanted to investigate the use and unreported use of psychotropic drugs by analyzing for a broad spectrum of drugs in the serum samples. Methods A total of 236 patients were included. Drug use, patient characteristics, and diagnoses were recorded, and serum analysis was performed for a total of 56 psychotropic drugs in 233 of the patients. Results Nine out of ten patients (88 %) used one or more psychotropic drugs on admission to hospital; the mean use was 2.8 (95 % confidence interval (CI) 2.6-2.9) drugs. In 25 patients (11 %), drugs reported used were not detected in serum. Unreported use of drugs (serum analysis revealing one or more drugs not reported) was found in 100 patients (43 %). This was more common in younger patients. Psychotropic polypharmacy (use of three or more psychotropic drugs) was found in 109 patients (47 %). Patients with a main diagnosis of affective disorder used the most psychotropic drugs. Conclusions Psychotropic drugs are commonly used among geriatric psychiatric patients on admission to hospital. Psychotropic polypharmacy is a major concern among these patients. There was considerable unreported use of drugs within this population, and a low threshold for a broader serum analysis for psychotropic drugs appears indicated.
Introduction
Elderly patients are major recipients of psychotropic drugs, but the use of these drugs is not previously well described in the population of geriatric psychiatric patients [1] . Polypharmacy is an increasing problem among the elderly [2] and is a known risk factor for morbidity [2] . Due to changes in pharmacokinetics and pharmacodynamics, older patients are probably exposed to and more vulnerable to higher serum concentrations [3, 4] . Drug-or medicinerelated problems (MRP) are well-known causes of admissions to hospitals [5] and important to consider in elderly patients with extensive drug use.
How psychotropic drugs are used by the patient is important knowledge as non-adherence generally increases the need for inpatient treatment [6] [7] [8] . Adherence to medication can be defined as "the extent to which patients take medication as prescribed by their health care provider" [9] , but different definitions have been used to assess adherence in the elderly [10] . In the general population, adherence to psychotropic drugs varies by drug class, being the lowest, at about 50 %, for antidepressants and mood stabilizers [11] . The relationship between adherence to medication and age is still unclear [12] [13] [14] [15] [16] [17] [18] .
Methods for measuring adherence can be either direct or indirect. Most studies use indirect measurements, such as selfreports, pill counts, or rates of prescription refills [9] . Direct measurements include the use of observed drug intake and serum analysis. The question of which methods should be used among older patients remains to be answered [10] . Serum analysis has been used in adults, studying serum concentration levels in relation to self-reports. This study showed an adherence rate of 62 % [19] but only investigated one defined main drug.
In addition, unreported use of drugs is important information for the clinical treatment of geriatric psychiatric patients. For the unreported use of drugs in general, a study on elderly outpatients found that half of the patients reported use of one or more drugs not reported by their general practitioner, most often a benzodiazepine [20] . The only direct and objective way to measure the use of unreported drugs is by applying serum analysis.
Knowledge of psychotropic drug use and the extent to which patients actually take their prescribed medications is important for clinical practice in geriatric psychiatry. Studies on adherence and unreported use, analyzing serum samples for a broad spectrum of psychotropic drugs, would therefore be of value.
The aim of this study was to describe the type, the number, and the serum concentration levels of psychotropic drugs in elderly patients, on admission to a geriatric psychiatric inpatient unit. The use and unreported use of psychotropic drugs, among these patients, were also investigated, by analyzing for a broad spectrum of drugs in the serum samples.
Methods

Participants
The study was an observational study, including all patients admitted to the Department of Geriatric Psychiatry at Diakonhjemmet Hospital in Oslo, Norway, during the study period. The department admits patients from the age of 60 and above, from a catchment area of approximately 250,000 inhabitants, requiring hospital admission due to psychiatric illness, irrespective of cognitive function and whether the illness is age-related or not. Patients are mostly referred from their general practitioner and some from nursing home doctors or other parts of the specialist service, such as acute psychiatric wards or geriatric departments in somatic hospitals. The department does not serve as an emergency ward, and all admissions are planned. The patients are admitted to one of three wards, treating affective disorders, psychosis, and symptoms of dementia, respectively. In Norway, psychiatric services are publicly funded.
All patients, admitted during the time period between the 6th of December 2006 and the 24th of October 2008, were asked to take part in the present study. The exclusion criteria were as follows: patients planned for electroconvulsive treatment; patients with a short expected stay in the department; and patients, or the next of kin, being unable to sign the informed consent form required for participation. A total of 372 patients were rendered eligible for inclusion. Of these, 57 patients did not give their consent, 28 patients were deemed not liable to give their consent and had either no relatives or no way of getting in contact with their relatives, and 11 patients had missing data. Thereby, 276 patients were included in the study, with 40 patients withdrawing their consent or being admitted to another department during the study, leaving 236 patients (63 %) entering the study. Serum analysis was missing for three of these patients, leaving a total of 233 patients.
Drug use and drug analysis
The referring doctors' information on patient drug use was registered on admission. Serum samples were collected in the morning on the day after admission, before any drug was given. The serum samples were analyzed at the Center for Psychopharmacology, Diakonhjemmet Hospital, in Oslo, with the analysis including all antidepressants and antipsychotics with market authorization in Norway, as well as the most commonly prescribed anticonvulsants and benzodiazepines, totaling 56 drugs. An ultra-performance liquid chromatography-mass spectrometry (UPLC-MS/MS) method, developed for routine therapeutic drug monitoring (TDM) at the Center for Psychopharmacology, was applied for the analyses of all drugs, except for that of lithium. Lithium was analyzed using an ion-selective electrode measurement. Validation parameters for imprecision and inaccuracy were <15 % for all analytes. All of the analytical assays had been validated and certified for routine TDM. The laboratory has been accredited since 2007, NS-EN ISO 15189 Medical laboratories, particular requirements for quality and competence. The reference range for each psychotropic drug was derived in the laboratory, based on the laboratory's extensive database and experience, and in cooperation with other Norwegian laboratories.
Users of a specific drug were defined as "patients with a positive serum sample on admission," and a supra-therapeutic concentration of a drug was defined as "above the reference range" for the specific drug, as defined for each drug by the Center for Psychopharmacology [21] .
Users of a specific psychotropic drug after 4 weeks of hospitalization were defined as "patients who were administered the specific drug within the ward." The dosages of the drugs were converted to a defined daily dosage (DDD) [22] . This international classification system of drugs and dosages enables comparison of drug use between different countries. Polypharmacy has been defined in many ways in different studies [23] . The use of two or three psychotropic drugs has been applied to define psychotropic polypharmacy, in some studies [24, 25] . This study defined polypharmacy as "the use of three or more psychotropic drugs."
Diagnoses
The diagnoses of the patients were recorded on discharge. Diagnoses were set by the physician that was responsible for the patient during the hospital stay and were based on all of the available information obtained during the patient's stay. Four main diagnostic categories were created for this study: main diagnosis of dementia, main diagnosis of affective disorders, main diagnosis of psychosis, and other main diagnosis. The category of "other main diagnosis" included mainly personality disorders, alcohol or drug dependence, and organic causes of psychiatric symptoms (including patients with delirium).
Assessments
On admission, the Mini Mental Status Evaluation (MMSE), a cognitive test, was performed. The severity of depression was measured by the Montgomery and Aasberg Depression Rating Scale (MADRS).
Ethics
The study was approved by the Regional Committee for Research Ethics in Norway and the Norwegian Medicines Agency. All patients or their next of kin (if the patients did not have the capacity to consent on their own) signed the informed consent form before attending the study.
Statistics
IBM SPSS® software version 21.0 (SPSS Inc., Chicago, IL, USA) was used for the statistical analyses. Mean values and 95 % confidence intervals (CIs) were reported for the continuous variables, and the frequency distributions were reported for the categorical variables. For the comparison between the groups, the independent Student's t test was used for the continuous variables, and for the categorical variables, Pearson's chi-squared test was applied.
Results
Patient characteristics for the total group are shown in Table 1 . A total of 206 patients, of the 233 patients (88 %) included, used one or more psychotropic drugs on admission, with the mean use being 2.8 (2.6-2.9) drugs. Of these, 47 patients used one, 50 patients used two, 50 patients used three, 34 patients used four, 17 patients used five, and 8 patients used six psychotropic drugs. Concomitant use of two or more psychotropic drugs was thus found in 159 of the patients (68 %), and polypharmacy (the use of three or more drugs) was detected in 109 of the patients (47 %). The mean dosage was below 1 DDD for all drug groups, except for the antidepressants, where the average dosage was 1.2 (1.1-1.4) DDD per day. When combining all psychotropic drugs, the mean dosage was 1.5 (1.4-1.7) DDD per patient, among those patients using psychotropic drugs.
The number of users of each drug class on admission, according to the serum analyses, and after 4 weeks, according to reported use from the hospital chart, is presented in Table 2 . After 4 weeks of hospitalization, the number of users in each drug class was no different from the number at the time of admission, except for the number of benzodiazepine users, which was reduced from 159 to 107 (p<0.001).
Inconsistencies between reported drug use and results of serum analysis on admission to hospital are shown in Table 3 . Patients with serum concentration levels above the recommended reference range varied between one patient for the anticonvulsants and 28 patients for benzodiazepines (see Table 3 ).
For 25 of the patients (11 %), drugs reported used were not detected in the serum analyses. These patients had a mean age of 75 years (72.1-77.9), which was significantly lower than that of the rest of the patients, with a mean age of 79.1 years (77.8-80.3) (p=0.037). They also had a higher score on the MMSE, a mean of 27.3 (26.1-28.5) (p=0.008), compared to the rest with a mean of 23.8 (22.9-24.7). For the other patient characteristics (demographics and diagnoses, as listed in Table 1 ), there were no significant differences between these two groups.
Unreported use of drugs (serum analysis revealing one or more unreported drugs) was detected in 100 (43 %) of the patients, as presented in Table 3 . The two antipsychotics most frequently used "on demand," chlorprotixene and levomepromazine, counted for 15 of the 35 unreported uses of antipsychotics. The patients showing unreported use were significantly younger compared with the remaining group of patients (p=0.003). There were no other significant differences between the group revealing unreported use and the rest of the patients, with regard to the other patient characteristics.
A total of 24 patients lived in nursing homes. Of these, ten patients (42 %) revealed unreported use of drugs and three patients (13 %) reported drug use that was not detected in the serum samples. These findings were no different from the findings among the home-dwelling patients. Sixty-six of the home-dwelling patients received home services, among which 24 (36 %) did not report use of drugs that were detected in serum, whereas three (5 %) reported use of drugs that were not detected. These numbers were likewise no different from those of the remaining group of patients, those not receiving home services.
The patients with a main diagnosis within the affective disorders used significantly more psychotropic drugs, compared both with the patients with a main diagnosis of dementia (p=0.010) and with the patients with a diagnosis of psychosis (p=0.044). There was no significant difference in the number of patients with unreported use or reported drug use not detected in serum between the groups, based on different diagnoses. The results, according to the four main diagnosis groups, are shown in Table 4 .
Discussion
This study showed that almost 90 % of the patients used psychotropic drugs on admission to a geriatric psychiatric hospital, with an average of 2.8 drugs. Psychotropic polypharmacy was frequently observed, as nearly half of the patients used three or more psychotropic drugs. Dosages of the psychotropic drugs used were low, and few patients showed serum concentrations above the recommended reference range. A negative serum analysis result, despite reported usage, was observed in one out of ten patients. Non-reported use was, in comparison, four times more frequent.
Concurrent use of three or more psychotropic drugs should be avoided in the elderly [25] . In the present study, polypharmacy was particularly seen in patients with affective disorders, and these findings are in accordance with those of previous studies. Several studies have investigated and reported on psychotropic polypharmacy [26] [27] [28] [29] [30] , an increasingly important issue [24, 31] . Polypharmacy has been reported to increase the risk of adverse effects [32, 33] , and the probability of drug-drug interactions increases with the number of drugs used [34] .
The dosages administered in the present study were below 1 DDD per day for all drug groups, except for the antidepressants, with a few serum samples showing concentrations above the therapeutic range. As for the dosages of the psychotropic drugs, a previous Norwegian study showed that among patients older than 65 years, the median dosage was 1.4 DDD [35] , whereas the median DDD in the present study was 1 (mean 1.5). Dosages of psychotropic drug use in geriatric psychiatric patients have been described in a study from the UK [36] . This study reported use of antipsychotics and antidepressants similar to what was found in the present study, but the patients in this study used more benzodiazepines. In mental illness, non-adherence to drugs is a well-known risk factor for hospitalization [6, 8, 37] . The consistency between reported and actual use of antidepressants, antipsychotics, and anticonvulsants, in the present study, was far better than what has previously been reported for any use of psychotropic drugs compared to the general elderly population [18] and for benzodiazepines in the same population [38] . Adherence can be defined in many ways and was not measured in the present study. However, a low percentage of patients with lack of reported drugs in serum indicates that adherence was good, and thereby probably not a major cause of admission, unlike what has previously been concluded in studies from other hospital departments [32, 39] . MRP are well-known causes of admissions to hospitals [5] . These causes could include toxicity due to supra-therapeutic concentrations, polypharmacy, and non-adherence. For the patients in this study, neither supra-therapeutic concentrations nor nonadherence was frequent. Although polypharmacy was observed, the suspicion of a considerable amount of MRPs was low. Unreported use of drugs was, however, more frequent and could complicate the treatment of these patients in hospital. This should be kept in mind by the physicians, which should consider objective ways to measure drug use. There is no reason to suspect that unreported use of drugs is more common in Norway than other countries, but studies on unreported drug use revealed by serum analysis are lacking.
In the present study, one surprising finding was that nonuse and unreported use were no different in the nursing home patients than in the home-dwelling patients. The number of patients in nursing homes (n=24) was too low to generalize but may serve as a reminder to doctors that they often lack exact information on the patient's actual use of drugs, also among institutionalized patients.
Younger age was the only significant factor that could be related to unreported use and to negative serum analysis Table 3 Number of patients with drugs detected in serum but not reported on admission, patients with drugs reported but not detected in serum, and patients with serum concentration levels above recommended reference ranges (n=233) results despite reported use. The patients with a negative serum analysis also had a higher score on the MMSE, indicating that cognitive difficulties were not the main cause. The results reported in previous literature within this field are contradictory [12] [13] [14] [15] [16] . Family members most probably assist older patients in the administration of drugs compared with those of younger patients, contributing to increased adherence in the older population. The group revealing a negative serum analysis result despite reported use was small (n=25), and more complex statistical analyses could not be performed. Although home services would be expected to increase adherence, adherence has also been shown to vary within the group receiving this service [40] . In studies of drug adherence, serum analyses are rarely performed, being as they are costly and must follow a standard protocol. Indirect measurements, such as self-reports or physician reports, are more commonly used. One larger study, including serum analysis, demonstrated that self-report questionnaires were a valid method for measuring adherence in patients with severe mental disorders [19] , but another study, on patients with schizophrenia, showed that patients' and physicians' reports were not able to identify adherence when comparing the reports to serum concentrations of drugs [41] . Strengths of this study were that serum analysis of drugs was performed and, particularly, that the study included a total of 56 psychotropic drugs, analyzed in all patients, providing a comprehensive picture of the psychotropic drug use, as either reported or not. All serum samples were collected in the morning on the day after admission, before any drugs were consumed. No drug regimen was changed before the blood samples were taken, the analysis thereby giving a detailed picture of which drugs the patients were using before the time of admission.
One weakness of the present study was that when defining drug use as "present in serum analysis," it could overestimate the use of drugs that are only consumed intermittently, such as long-acting benzodiazepines and some antipsychotics. This overestimation is less likely the case for antidepressants, anticonvulsants, and most antipsychotics, which are drugs most commonly prescribed for daily use. For short-acting benzodiazepines, the use may conversely be underestimated. The serum concentration levels only reflect on the drugs used during the past few days before admission, and average use for longer time periods was not registered. Knowledge of the latter could possibly be provided by retrieving information from several sources, such as pharmacy records [42] .
In conclusion, psychotropic drugs are commonly used among geriatric psychiatric patients on admission to hospital. Psychotropic polypharmacy is a major concern with this group of patients and even more so among patients with affective disorders than among patients with dementia. Absence of reported drug use in serum may indicate nonadherence, which is an important factor for patient outcome, hospitalization, and health care costs in general. The present study found this finding to be less frequent than expected, compared with previous reports of non-adherence to drugs. Unreported use of drugs was, however, a bigger issue, and a low threshold for a broader serum analysis of psychotropic drugs appears to be indicated. With considerable unreported use of antidepressants, antipsychotics, and benzodiazepines, this finding is important to bear in mind when diagnosing and treating elderly psychiatric patients.
